Natural Product: NPC315320| Natural Product ID | NPC315320 |
|
Common Name
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
| Risedronic Acid |
| IUPAC Name | hydroxy-(1-hydroxy-1-phosphono-2-pyridin-1-ium-3-ylethyl)phosphinate |
| Synonyms | Actonel; NE-58095; Risedronate; Risedronic Acid |
| Synthetic Gene Cluster | n.a. |
| ChEMBL Identifier | CHEMBL923 |
| PubChem CID |
44400168 5245 |
| Chemical Classification |
|
The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.
Chemical Representations
| Standard InCHIKey | IIDJRNMFWXDHID-UHFFFAOYSA-N |
| Standard InCHI | InChI=1S/C7H11NO7P2/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15) |
| SMILES | C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)O |
  Calculated Properties| Molecular Weight:   | 283.0 | Volume:   | 225.345 Van der Waals volume.
|
| Dense:   | 1.256 | LogP:   | -0.982 The logarithm of the n-octanol/water distribution coefficients.
|
| logD7.4:   | -0.186 The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
|
LogS:   | -0.538 The logarithm of aqueous solubility value.
|
| Rotatable Bonds:   | 4.0 | Rigid Bonds:   | 8.0 |
| TPSA:   | 148.18 Topological Polar Surface Area.
|
H-Bond Acceptor:   | 8.0 |
| H-Bond Donor:   | 5.0 | Rings:   | 1.0 |
| Heavy Atoms:   | 10.0 |
| QED Drug-Likeness Score:   | 0.47 | GASA:   | 1.0 GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
|
| Synthetic Accessibility Score:   | 2.886 | Fsp3:   | 0.286 |
| MCE-18:   | 13.0 MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
|
Lipinski Rule-of-5:   | Rejected |
| Pfizer Rule:   | Rejected | GSK Rule:   | Rejected |
| Golden Triangle Rule:   | Rejected | BMS Rule:   | 1 |
| Chelating Alert:   | 0 | PAINS Alert:   | 0 |
| Colloidal aggregators:   | 0.002 | Fluc inhibitor:   | 0.0 The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
|
| Blue fluorescence:   | 0.022 The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
|
Green fluorescence:   | 0.029 The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
|
| Reactive compounds:   | 0.154 | Promiscuous compounds:   | 0.052 |
| Caco-2 Permeability:   | -6.433 | MDCK Permeability:   | -4.844 |
| Pgp-inhibitor:   | 0.0 | Pgp-substrate:   | 0.0 |
| PAMPA:   |
1.0 The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
|
Human Intestinal Absorption (HIA):   | 1.0 |
| 20% Bioavailability (F20%):   | 1.0 | 30% Bioavailability (F30%):   | 1.0 |
| 50% Bioavailability (F50%):   | 1.0 |
| Blood-Brain-Barrier Penetration (BBB):   | 0.0 | MRP1:   | 0.944 |
| Plasma Protein Binding (PPB):   | 38.761% | Volume Distribution (VD):   | 0.696 |
| Fu: |
55.149% The fraction unbound in plasms.
|
OATP1B1 inhibitor:   | 0.0 |
| OATP1B3 inhibitor:   | 0.0 | BCRP inhibitor:   | 0.0 |
| BSEP inhibitor:   | 0.0 |
| CYP1A2-inhibitor:   | 0.0 | CYP1A2-substrate:   | 0.0 |
| CYP2C19-inhibitor:   | 0.0 | CYP2C19-substrate:   | 0.205 |
| CYP2C9-inhibitor:   | 0.996 | CYP2C9-substrate:   | 0.0 |
| CYP2D6-inhibitor:   | 0.0 | CYP2D6-substrate:   | 0.0 |
| CYP3A4-inhibitor:   | 0.0 | CYP3A4-substrate:   | 0.0 |
| CYP2B6-substrate:   | 0.0 | CYP2C8-inhibitor:   | 0.318 |
| HLM stability:   |
0.001 Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.
|
| Clearance (CL):   | 1.658 | Half-life (T1/2):   | 2.082 |
| hERG Blockers:   | 0.0 | hERG Blockers (10um):   | 0.0 |
| Human Hepatotoxicity (H-HT):   | 0.961 | Drug-induced Liver Injury (DILI):   | 0.006 |
| AMES Toxicity:   | 0.002 | Rat Oral Acute Toxicity:   | 0.002 |
| Maximum Recommended Daily Dose:   | 0.998 | Skin Sensitization:   | 0.57 |
| Carcinogencity:   | 0.979 | Eye Corrosion:   | 0.994 |
| Eye Irritation:   | 0.383 | Respiratory Toxicity:   | 0.937 |
| Drug-induced Neurotoxicity:   | 0.002 | Ototoxicity:   | 0.993 |
| Hematotoxicity:   | 0.118 | Drug-induced Nephrotoxicity:   | 1.0 |
| Genotoxicity:   | 0.982 | RPMI-8226 Immunitoxicity:   | 0.011 |
| A549 Cytotoxicity:   | 0.0 | Hek293 Cytotoxicity:   | 0.005 |
| BCF:   |
0.082 Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
|
IGC50:   |
2.481 48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
|
| LC50DM:   |
3.606 48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
|
LC50FM:   |
3.042 96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].
|
  Species Source| Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
|---|---|---|---|---|---|---|---|---|
| NPO7937 | Os sepiae seu sepiellaezoological name | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[COCONUT] |
| NPO22587 | Herba serissae | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[COCONUT] |
| NPO24859 | Concha haliotidis | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[COCONUT] |
| NPO13165 | Concha cyclinae | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[COCONUT] |
| NPO9869 | Crassostrea gigas | Species | Ostreidae | Eukaryota | n.a. | n.a. | n.a. | Database[COCONUT] |
| NPO15173 | Concha meretricis seu cyclinae | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[COCONUT] |
| NPO9869 | Crassostrea gigas | Species | Ostreidae | Eukaryota | n.a. | n.a. | n.a. | Database[HerDing] |
| NPO24859 | Concha haliotidis | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[HerDing] |
| NPO560 | Os corallii | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[HerDing] |
| NPO13037 | Os draconis | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[HerDing] |
| NPO13165 | Concha cyclinae | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[HerDing] |
| NPO15987 | Plastrum testudinis | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[HerDing] |
| NPO23812 | Concha arcae | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[HerDing] |
| NPO25192 | Cornu cervi | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[HerDing] |
| NPO357 | Calcitum | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO15173 | Concha meretricis seu cyclinae | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO23462 | Coridius | Species | Dinidoridae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO22587 | Herba serissae | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO13165 | Concha cyclinae | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO24859 | Concha haliotidis | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO19431 | Ophicalcitum | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO16871 | Eriocheir sinensis seu poramon | Species | Varunidae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO5962 | Concha arcae preparata | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO14095 | Os draconis preparata | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO23812 | Concha arcae | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO13037 | Os draconis | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO9753 | Concha margaritifera usta | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO29636 | Rhinoceros sondaicus | Species | Rhinocerotidae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO328 | Plastrum testudinis praparata | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO7937 | Os sepiae seu sepiellaezoological name | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO20831 | Rhinoceros sumatrensis | Species | Rhinocerotidae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO9869 | Crassostrea gigas | Species | Ostreidae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO29693 | Rhinoceros unicornis | Species | Rhinocerotidae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO3716 | Pulvis cornu cervi | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO25192 | Cornu cervi | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO1985 | Caulis rubi idaei | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO15987 | Plastrum testudinis | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO17349 | Colla carapacis et plastri testudinis | Species | Bombycidae | Eukaryota | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO28283 | Margarita | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO6651 | Cornu cervi degelatinatum | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO560 | Os corallii | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | Database[TCMID] |
| NPO20831 | Rhinoceros sumatrensis | Species | Rhinocerotidae | Eukaryota | n.a. | n.a. | n.a. | Database[TCM_Taiwan] |
| NPO9869 | Crassostrea gigas | Species | Ostreidae | Eukaryota | n.a. | n.a. | n.a. | Database[UNPD] |
Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
  NP Quantity Composition/Concentration| Organism ID | Organism Name | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
|---|
Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Biological Activity
| Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
|---|---|---|---|---|---|---|---|---|
| NPT1495 | Individual protein | Geranylgeranyl pyrophosphate synthetase | Homo sapiens | IC50 | = | 350000.0 | nM | PMID[12014956] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 10.0 | nM | PMID[21780776] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 170.0 | nM | PMID[14613320] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | Ki | = | 16.0 | nM | PMID[14613320] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 169.82 | nM | PMID[14613320] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 452.9 | nM | PMID[18327899] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | Ki | = | 82.2 | nM | PMID[18327899] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 5.7 | nM | PMID[18434151] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | Ki | = | 0.36 | nM | PMID[18327899] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | Inhibition | = | 57.0 | % | PMID[18590315] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 300.0 | nM | PMID[20801032] |
| NPT1495 | Individual protein | Geranylgeranyl pyrophosphate synthetase | Homo sapiens | Ki | = | 8300000.0 | nM | PMID[20457823] |
| NPT1495 | Individual protein | Geranylgeranyl pyrophosphate synthetase | Homo sapiens | IC50 | = | 300000000.0 | nM | PMID[20457823] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 11.0 | nM | PMID[25630225] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | Inhibition | > | 80.0 | % | PMID[22390415] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 860.0 | nM | PMID[22390415] |
| NPT1495 | Individual protein | Geranylgeranyl pyrophosphate synthetase | Homo sapiens | IC50 | > | 100000.0 | nM | PMID[22390415] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | Ratio IC50 | = | 78.0 | n.a. | PMID[22390415] |
| NPT1495 | Individual protein | Geranylgeranyl pyrophosphate synthetase | Homo sapiens | Inhibition | < | 50.0 | % | PMID[22884353] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | Ratio IC50 | <= | 2.0 | n.a. | PMID[23998921] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 5.2 | nM | PMID[23998921] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | Ratio | = | 0.004 | n.a. | PMID[24911527] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 6.0 | nM | PMID[25935643] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | Delta Tm | = | 22.0 | degrees C | PMID[24911527] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | Delta Tm | = | 30.0 | degrees C | PMID[24911527] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 0.36 | nM | PMID[25815158] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 82.0 | nM | PMID[25815158] |
| NPT1495 | Individual protein | Geranylgeranyl pyrophosphate synthetase | Homo sapiens | Inhibition | = | 17.0 | % | PMID[30216851] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | Inhibition | = | 93.5 | % | PMID[30216851] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 70.0 | nM | PMID[30216851] |
| NPT246 | Individual protein | Dopamine transporter | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT292 | Individual protein | Serotonin 2c (5-HT2c) receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT303 | Individual protein | Vasopressin V1a receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT108 | Individual protein | Estrogen receptor alpha | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT1814 | Individual protein | Glucagon receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT223 | Individual protein | Alpha-2b adrenergic receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT242 | Individual protein | Dopamine D1 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT299 | Individual protein | Androgen Receptor | Rattus norvegicus | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT261 | Individual protein | Monoamine oxidase A | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT248 | Individual protein | Estrogen receptor beta | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT1407 | Individual protein | GABA-B receptor 1 | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT217 | Individual protein | Adenosine A2a receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT297 | Individual protein | Neurokinin 1 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT31 | Individual protein | Cyclooxygenase-2 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT264 | Individual protein | Muscarinic acetylcholine receptor M3 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT262 | Individual protein | Muscarinic acetylcholine receptor M1 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT1410 | Individual protein | GABA receptor alpha-1 subunit | Rattus norvegicus | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT222 | Individual protein | Alpha-2a adrenergic receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT216 | Individual protein | Adenosine A1 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT271 | Individual protein | Delta opioid receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT291 | Individual protein | Serotonin 2b (5-HT2b) receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT239 | Individual protein | Cholecystokinin A receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT1788 | Individual protein | Alpha-1a adrenergic receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT290 | Individual protein | Serotonin 2a (5-HT2a) receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT227 | Individual protein | Beta-3 adrenergic receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT232 | Individual protein | Cannabinoid CB1 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT243 | Individual protein | Dopamine D2 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT291 | Individual protein | Serotonin 2b (5-HT2b) receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT2769 | Individual protein | Thromboxane A2 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT230 | Individual protein | Bradykinin B2 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT1647 | Individual protein | Vasopressin V2 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT272 | Individual protein | Kappa opioid receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT232 | Individual protein | Cannabinoid CB1 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT252 | Individual protein | Histamine H2 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT259 | Individual protein | Melanocortin receptor 4 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT228 | Individual protein | Norepinephrine transporter | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT145 | Individual protein | Mu opioid receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT1785 | Individual protein | Serotonin 7 (5-HT7) receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT1384 | Individual protein | Farnesyl diphosphate synthase | Homo sapiens | IC50 | = | 3.9 | nM | PMID[34236862] |
| NPT226 | Individual protein | Beta-2 adrenergic receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT244 | Individual protein | Dopamine D3 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT263 | Individual protein | Muscarinic acetylcholine receptor M2 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT290 | Individual protein | Serotonin 2a (5-HT2a) receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT245 | Individual protein | Dopamine D4 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT251 | Individual protein | Histamine H1 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT222 | Individual protein | Alpha-2a adrenergic receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT295 | Individual protein | Serotonin transporter | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT218 | Individual protein | Adenosine A3 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT2879 | Individual protein | Equilibrative nucleoside transporter 1 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT267 | Individual protein | Neuropeptide Y receptor type 1 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT225 | Individual protein | Beta-1 adrenergic receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT1788 | Individual protein | Alpha-1a adrenergic receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT249 | Individual protein | Glucocorticoid receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT247 | Individual protein | Endothelin receptor ET-A | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT2719 | Individual protein | Voltage-gated L-type calcium channel alpha-1C subunit | Rattus norvegicus | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT242 | Individual protein | Dopamine D1 receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT1163 | Individual protein | Glutamate (NMDA) receptor subunit zeta 1 | Rattus norvegicus | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT294 | Individual protein | Serotonin 6 (5-HT6) receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT2856 | Individual protein | Sodium channel protein type V alpha subunit | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT1464 | Individual protein | Phosphodiesterase 4D | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT224 | Individual protein | Alpha-2c adrenergic receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT5935 | Individual protein | Farnesyl diphosphate synthase | Trypanosoma cruzi | IC50 | = | 27.0 | nM | PMID[23318904] |
| NPT30134 | Single protein | Gastric inhibitory polypeptide receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT987 | Individual protein | Histamine H3 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT5301 | Individual protein | Motilin receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT5318 | Individual protein | Corticotropin releasing factor receptor 1 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT5931 | Individual protein | Farnesyl pyrophosphate synthase | Leishmania donovani | IC50 | = | 170.0 | nM | PMID[16392806] |
| NPT5931 | Individual protein | Farnesyl pyrophosphate synthase | Leishmania donovani | Ki | = | 17.0 | nM | PMID[15828834] |
| NPT5931 | Individual protein | Farnesyl pyrophosphate synthase | Leishmania donovani | IC50 | = | 169.82 | nM | PMID[16392806] |
| NPT5937 | Individual protein | 4-hydroxy-3-methylbut-2-enyl diphosphate reductase | Aquifex aeolicus (strain VF5) | IC50 | > | 1000000.0 | nM | PMID[20426416] |
| NPT20556 | Single protein | Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | -4.82 | % | DOI[10.6019/CHEMBL4495564] |
| NPT26693 | Single protein | Butyrophilin subfamily 3 member A1 | Homo sapiens | EC50 | = | 80.0 | nM | PMID[32930595] |
| NPT3952 | Individual protein | Endothelin receptor ET-B | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT4358 | Individual protein | Type-1 angiotensin II receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT542 | Individual protein | Progesterone receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT3735 | Individual protein | Neurotensin receptor 1 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT77 | Individual protein | Transthyretin | Homo sapiens | Activity | = | 5.7 | % | PMID[34547896] |
| NPT77 | Individual protein | Transthyretin | Homo sapiens | Activity | = | 62.0 | % | PMID[34547896] |
| NPT692 | Individual protein | Histone deacetylase 6 | Homo sapiens | Inhibition | = | -20.04 | % | HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators |
| NPT77 | Individual protein | Transthyretin | Homo sapiens | Activity | = | 11.0 | % | PMID[34547896] |
| NPT692 | Individual protein | Histone deacetylase 6 | Homo sapiens | Inhibition | = | -5.96 | % | HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators |
| NPT77 | Individual protein | Transthyretin | Homo sapiens | Activity | = | 94.0 | % | PMID[34547896] |
| NPT29430 | Single protein | Neuronal acetylcholine receptor protein alpha-4 subunit | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT98 | Individual protein | HERG | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT4729 | Individual protein | Cholecystokinin B receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT5936 | Individual protein | Farnesyl diphosphate synthase | Toxoplasma gondii | IC50 | = | 74.0 | nM | PMID[24300918] |
| NPT23182 | Macromolecule | Hydroxyapatite | Homo sapiens | Activity | = | 87.0 | % | PMID[30216851] |
| NPT27367 | Single protein | Farnesyl pyrophosphate synthase | Leishmania major | Ki | = | 16.0 | nM | PMID[32979487] |
| NPT28448 | Single protein | Corticotropin releasing factor receptor 2 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT28814 | Single protein | Ghrelin receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT92 | Individual protein | Serotonin 1a (5-HT1a) receptor | Homo sapiens | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT5975 | Individual protein | Cyclooxygenase-1 | Rattus norvegicus | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT28787 | Single protein | Voltage-gated N-type calcium channel alpha-1B subunit | Rattus norvegicus | AC50 | > | 10000.0 | nM | PMID[37468498] |
| NPT92 | Individual protein | Serotonin 1a (5-HT1a) receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT6127 | Individual protein | Bradykinin B1 receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT5104 | Individual protein | Phosphodiesterase 3A | Homo sapiens | AC50 | = | 7141.4 | nM | PMID[37468498] |
| NPT20859 | Single protein | Neuropeptide Y receptor type 2 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT5932 | Individual protein | Vacuolar-type proton translocating pyrophosphatase 1 | Trypanosoma brucei | IC50 | = | 656700.0 | nM | PMID[16162013] |
| NPT5932 | Individual protein | Vacuolar-type proton translocating pyrophosphatase 1 | Trypanosoma brucei | TI | = | 0.4 | n.a. | PMID[16162013] |
| NPT5933 | Individual protein | Hexokinase | Trypanosoma cruzi | IC50 | >= | 300000.0 | nM | PMID[16392806] |
| NPT5933 | Individual protein | Hexokinase | Trypanosoma cruzi | IC50 | = | 301995.17 | nM | PMID[16392806] |
| NPT5 | Individual protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | n.a. | 17782.8 | nM | PubChem BioAssay data set |
| NPT23196 | Single protein | 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase | Homo sapiens | Activity | = | 17.4 | % | PMID[33369426] |
| NPT23196 | Single protein | 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase | Homo sapiens | Activity | = | 82.7 | % | PMID[33369426] |
| NPT425 | Individual protein | Serotonin 3a (5-HT3a) receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT543 | Individual protein | Pregnane X receptor | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| NPT30151 | Single protein | Melanocortin receptor 3 | Homo sapiens | AC50 | > | 30000.0 | nM | PMID[37468498] |
| Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
|---|---|---|---|---|---|---|---|---|
| NPT189 | Cell line | Vero | Chlorocebus aethiops | Infected | = | 0.0 | % | PMID[11300872] |
| NPT859 | Cell line | HFF | Homo sapiens | IC50 | = | 2400.0 | nM | PMID[15857119] |
| NPT91 | Cell line | KB | Homo sapiens | ED50 | = | 255.0 | uM | PMID[16162013] |
| NPT83 | Cell line | MCF7 | Homo sapiens | IC50 | = | 35700.0 | nM | PMID[16970405] |
| NPT397 | Cell line | NCI-H460 | Homo sapiens | IC50 | = | 43700.0 | nM | PMID[16970405] |
| NPT395 | Cell line | SF-268 | Homo sapiens | IC50 | = | 23300.0 | nM | PMID[16970405] |
| NPT5934 | Cell line | 13762 | Rattus norvegicus | IC50 | > | 40000.0 | nM | PMID[16970405] |
| NPT389 | Cell line | RPMI-8226 | Homo sapiens | EC50 | = | 13000.0 | nM | PMID[23998921] |
| NPT83 | Cell line | MCF7 | Homo sapiens | IC50 | = | 248000.0 | nM | PMID[33132173] |
| NPT65 | Cell line | HepG2 | Homo sapiens | TC50 | = | 13.0 | mM | PMID[20457823] |
| NPT844 | Organism | Trypanosoma brucei rhodesiense | Trypanosoma brucei rhodesiense | IC50 | = | 8600.0 | nM | PMID[12086478] |
| NPT844 | Organism | Trypanosoma brucei rhodesiense | Trypanosoma brucei rhodesiense | IC50 | = | 8511.38 | nM | PMID[12086478] |
| NPT844 | Organism | Trypanosoma brucei rhodesiense | Trypanosoma brucei rhodesiense | Inhibition | = | 100.0 | % | PMID[12086478] |
| NPT844 | Organism | Trypanosoma brucei rhodesiense | Trypanosoma brucei rhodesiense | Inhibition | = | 86.49 | % | PMID[12086478] |
| NPT844 | Organism | Trypanosoma brucei rhodesiense | Trypanosoma brucei rhodesiense | Inhibition | = | 23.49 | % | PMID[12086478] |
| NPT844 | Organism | Trypanosoma brucei rhodesiense | Trypanosoma brucei rhodesiense | Inhibition | = | 19.3 | % | PMID[12086478] |
| NPT844 | Organism | Trypanosoma brucei rhodesiense | Trypanosoma brucei rhodesiense | Inhibition | = | 0.0 | % | PMID[12086478] |
| NPT844 | Organism | Trypanosoma brucei rhodesiense | Trypanosoma brucei rhodesiense | IC50 | = | 4120.0 | nM | PMID[12086478] |
| NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 123000.0 | nM | PMID[20185316] |
| NPT992 | Organism | Entamoeba histolytica | Entamoeba histolytica | IC50 | = | 73500.0 | nM | PMID[14695831] |
| NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 130000.0 | nM | PMID[19053772] |
| NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 125892.54 | nM | PMID[19053772] |
| NPT992 | Organism | Entamoeba histolytica | Entamoeba histolytica | IC50 | = | 74000.0 | nM | PMID[20185316] |
| NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 1200.0 | nM | PMID[20457823] |
| NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 1400.0 | nM | PMID[20457823] |
| NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 16944.1 | nM | PubChem BioAssay data set |
| NPT20555 | Organism | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | -0.02 | % | DOI[10.6019/CHEMBL4495565] |
| NPT20555 | Organism | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 20000.0 | nM | DOI[10.6019/CHEMBL4651402] |
| NPT20555 | Organism | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 19952.62 | nM | DOI[10.6019/CHEMBL4651402] |
| NPT28438 | Unchecked | Unchecked | n.a. | IC50 | = | 440.0 | nM | PMID[34894691] |
| NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | IC50 | = | 123000.0 | nM | PMID[11300872] |
| NPT633 | Organism | Leishmania donovani | Leishmania donovani | IC50 | = | 2300.0 | nM | PMID[11300872] |
| NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | Inhibition | = | 100.0 | % | PMID[11300872] |
| NPT5128 | Organism | Dictyostelium discoideum | Dictyostelium discoideum | IC50 | = | 13000.0 | nM | PMID[18590315] |
| NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | IC50 | = | 300000.0 | nM | PMID[11277521] |
| NPT5128 | Organism | Dictyostelium discoideum | Dictyostelium discoideum | IC50 | = | 3000.0 | nM | PMID[16392806] |
| NPT20529 | Non-molecular | NON-PROTEIN TARGET | n.a. | EC50 | = | 10000.0 | nM | PMID[22390415] |
| NPT20529 | Non-molecular | NON-PROTEIN TARGET | n.a. | EC50 | = | 10600.0 | nM | PMID[22390415] |
| NPT580 | Organism | Trypanosoma cruzi | Trypanosoma cruzi | ED50 | = | 55.0 | uM | PMID[23318904] |
| NPT1018 | Organism | Trypanosoma brucei | Trypanosoma brucei | IC50 | = | 8600.0 | nM | PMID[11300872] |
| NPT19 | Organism | Escherichia coli | Escherichia coli | IZ | = | 0.0 | mm | PMID[17149863] |
| NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | IC50 | = | 16000.0 | nM | PMID[20457823] |
| NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 0.5 | day | PMID[20457823] |
| NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 1.0 | day | PMID[20457823] |
| NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 6.0 | day | PMID[20457823] |
| NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 4.0 | day | PMID[20457823] |
| NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 2.5 | day | PMID[20457823] |
| NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 2.0 | day | PMID[20457823] |
| NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 0.09 | % | PMID[20457823] |
| NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 8.0 | day | PMID[20457823] |
| NPT474 | Organism | Plasmodium berghei | Plasmodium berghei | Activity | = | 3.0 | day | PMID[20457823] |
| NPT2 | Others | Unspecified | n.a. | IC50 | = | 6900.0 | nM | PMID[14711309] |
| NPT2 | Others | Unspecified | n.a. | IC50 | = | 6918.31 | nM | PMID[14711309] |
| NPT2 | Others | Unspecified | n.a. | IC50 | = | 6200.0 | nM | PMID[14711309] |
| NPT2 | Others | Unspecified | n.a. | IC50 | = | 6165.95 | nM | PMID[14711309] |
| NPT486 | Organism | Toxoplasma gondii | Toxoplasma gondii | IC50 | = | 490.0 | nM | PMID[11300872] |
| NPT2 | Others | Unspecified | n.a. | IC50 | > | 3000000.0 | nM | PMID[14695831] |
| NPT2 | Others | Unspecified | n.a. | EC50 | = | 5000.0 | nM | PMID[15828834] |
| NPT2 | Others | Unspecified | n.a. | IC50 | = | 660000.0 | nM | PMID[17535895] |
| NPT2 | Others | Unspecified | n.a. | IC50 | = | 90.0 | nM | PMID[17535895] |
| NPT2 | Others | Unspecified | n.a. | IC50 | = | 38.0 | nM | PMID[17535895] |
| NPT2 | Others | Unspecified | n.a. | IC50 | = | 590.0 | nM | PMID[19053772] |
| NPT2 | Others | Unspecified | n.a. | IC50 | = | 630.96 | nM | PMID[19053772] |
| NPT2 | Others | Unspecified | n.a. | Ki | = | 24000.0 | nM | PMID[20457823] |
| NPT2 | Others | Unspecified | n.a. | Ki | = | 48000.0 | nM | PMID[20457823] |
| NPT2 | Others | Unspecified | n.a. | Ki | = | 13000.0 | nM | PMID[20457823] |
| NPT2 | Others | Unspecified | n.a. | IC50 | = | 1100000.0 | nM | PMID[20457823] |
| NPT2 | Others | Unspecified | n.a. | IC50 | = | 1700000.0 | nM | PMID[20457823] |
| NPT2 | Others | Unspecified | n.a. | IC50 | = | 110000.0 | nM | PMID[20457823] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_bilirubinemia | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_cholecystitis | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_cholelithiasis | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_cirrhosis | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_hepatic failure | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_hepatic necrosis | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_hepatomegaly | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_jaundice | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_liver fatty | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_liver function tests abnormal | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_Combined Scores | = | 0.0 | n.a. | PMID[22194678] |
| NPT2 | Others | Unspecified | n.a. | IC50 | > | 1000000.0 | nM | PMID[23266123] |
| NPT486 | Organism | Toxoplasma gondii | Toxoplasma gondii | ED50 | = | 2.4 | uM | PMID[24300918] |
| NPT2 | Others | Unspecified | n.a. | IC50 | = | 27.0 | nM | PMID[24300918] |
| NPT2 | Others | Unspecified | n.a. | IC50 | = | 300.0 | nM | PMID[25815158] |
| NPT486 | Organism | Toxoplasma gondii | Toxoplasma gondii | EC50 | = | 2400.0 | nM | PMID[34894691] |
| NPT20632 | Organism | Chikungunya virus | Chikungunya virus | Activity | = | 86.7 | % | PMID[36940609] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_liver disease | = | 0.0 | n.a. | PMID[22194678] |
| Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
|---|---|---|---|---|---|---|---|---|
| NPT32 | Organism | Mus musculus | Mus musculus | IC50 | = | 300.0 | nM | PMID[15828834] |
| NPT605 | Organism | Homo sapiens | Homo sapiens | Fg | = | 1.01 | n.a. | PMID[20070106] |
| NPT605 | Organism | Homo sapiens | Homo sapiens | F_fraction | = | 0.62 | n.a. | PMID[20070106] |
| NPT605 | Organism | Homo sapiens | Homo sapiens | Fa | = | 0.62 | n.a. | PMID[20070106] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LED | = | 0.0003 | mgP kg-1 | PMID[18327899] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LED | = | 0.0003 | mg kg-1 | PMID[18327899] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 48.0 | % | PMID[17870210] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Inhibition | = | 44.0 | % | PMID[17870210] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_elevated liver function tests | = | 0.0 | n.a. | PMID[22194678] |
| NPT20596 | Phenotype | Hepatotoxicity | n.a. | HepSE_hepatitis | = | 0.0 | n.a. | PMID[22194678] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | MED | = | 0.0003 | mg kg-1 | PMID[21780776] |
| NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | FC | = | 2000.0 | n.a. | PMID[33522236] |
Experimental ADME
| Experiment Model | Experiment Tissue | ADME Type | ADME Relation | ADME Value | ADME Unit | Reference |
|---|---|---|---|---|---|---|
| Homo sapiens | Plasma | Fu | = | 0.76 | n.a. | PMID[20070106] |
| Homo sapiens | n.a. | Fu | = | 0.76 | n.a. | PMID[18426954] |
Experimental Toxicity
| Experiment Model | Experiment Organism | Toxicity Type | Toxicity Relation | Toxicity Value | Toxicity Unit | Reference |
|---|
Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria
| Hepatotoxicity | Carcinogenicity | Mutagenicity | Cardiotoxicity | Respiratory Toxicity | Eye Irritation | Endocrine Disruption |
|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
☉ ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
☉ TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]
  Chemically structural similarityTop-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)
Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.
●  The left chart: Distribution of similarity level between NPC315320 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).
| Similarity Score | Similarity Level | Natural Product ID |
|---|---|---|
| 0.5484 | Remote Similarity | NPC27802 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC315320 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).
  Bioactivity similaritySimilarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.
